Abstract
This is a summary of the Third Annual Cancer Nanobiology Think Tank hosted by the Nanobiology Program at the Center for Cancer Research at the National Cancer Institute-Frederick, National Institutes of Health. The Third Annual Nanobiology Think Tank was held in May of 2008 and was entitled “Understanding the Design Principles of Living Systems at the Nanoscale.”
Keywords: Nanobiology, nanotechnology, cancer drug delivery, mechanical biology, single-molecule imaging, in vivo proteomics
Current Nanoscience
Title: Understanding the Design Principles of Living Systems at the Nanoscale
Volume: 5 Issue: 1
Author(s): Amy Jacobs and Robert Blumenthal
Affiliation:
Keywords: Nanobiology, nanotechnology, cancer drug delivery, mechanical biology, single-molecule imaging, in vivo proteomics
Abstract: This is a summary of the Third Annual Cancer Nanobiology Think Tank hosted by the Nanobiology Program at the Center for Cancer Research at the National Cancer Institute-Frederick, National Institutes of Health. The Third Annual Nanobiology Think Tank was held in May of 2008 and was entitled “Understanding the Design Principles of Living Systems at the Nanoscale.”
Export Options
About this article
Cite this article as:
Jacobs Amy and Blumenthal Robert, Understanding the Design Principles of Living Systems at the Nanoscale, Current Nanoscience 2009; 5 (1) . https://dx.doi.org/10.2174/157341309787314593
DOI https://dx.doi.org/10.2174/157341309787314593 |
Print ISSN 1573-4137 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6786 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Phase II Drug Metabolism and Individualized Drug Therapy: A Focus on Functional Genetic Variation in UDP-Glucuronosyltransferases
Current Pharmacogenomics and Personalized Medicine Advanced Echocardiographic Imaging of the Congenitally Malformed Heart
Current Cardiology Reviews Alternatives to Conventional Vaccines - Mediators of Innate Immunity
Current Drug Targets Role of Dendritic Cells in HIV-Immunotherapy
Current HIV Research Biotherapy for Autoimmune Liver Diseases
Current Pharmaceutical Biotechnology Antidepressants: Current Strategies and Future Opportunities
Current Pharmaceutical Design Interfering with Hedgehog Pathway: New Avenues for Targeted Therapy in Rhabdomyosarcoma
Current Drug Targets Viral Vectors in Cancer Immunotherapy: Which Vector for Which Strategy?
Current Gene Therapy Drug-Resistance in Central Nervous System Tumors: From the Traditional Cell-Resistance Model to the Genetically Driven Approaches on Therapy
Current Pharmaceutical Biotechnology Simultaneous Interruption of Signal Transduction and Cell Cycle Regulatory Pathways: Implications for New Approaches to the Treatment of Childhood Leukemias
Current Drug Targets Developing Novel Anticancer Drugs for Targeted Populations: An Update
Current Pharmaceutical Design Structural and Functional Organization of miRNAs
Current Pharmacogenomics Biliary Innate Immunity in the Pathogenesis of Biliary Diseases
Inflammation & Allergy - Drug Targets (Discontinued) Targeting Blood Vessels for the Treatment of Non-Small Cell Lung Cancer
Current Cancer Drug Targets Emergence of Methicillin-Resistant Staphylococcus aureus (MRSA) as a Public-Health Threat and Future Directions of Antibiotic Therapy for MRSA Infections
Anti-Infective Agents The Heart Metabolism: Pathophysiological Aspects in Ischaemia and Heart Failure
Current Pharmaceutical Design Non-canonical Molecular Targets for Novel Analgesics: Intracellular Calcium and HCN Channels
Current Neuropharmacology Development and Applications of Optical Imaging Techniques in Cancer Diagnosis: Diffuse Optical Tomography and Microendoscopy
Current Medical Imaging IL-1 as a target in inflammation
Endocrine, Metabolic & Immune Disorders - Drug Targets Why Some Messages Speak Better: Child Immunization in the News and on the Internet
Current Drug Safety